Evidence map›Paper›PMID 29439001›Full record

ArticleThe Journal of experimental medicine2018

The Cdx2 homeobox gene suppresses intestinal tumorigenesis through non-cell-autonomous mechanisms.

Camille Balbinot, Olivier Armant, Nabila Elarouci, Laetitia Marisa, Elisabeth Martin, Etienne De Clara, Alina Onea, Jacqueline Deschamps, Felix Beck, Jean-Noël Freund and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. SOX2 is required independently in both stem and differentiated cells for pituitary tumorigenesis inProceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  18. Article
  19. Article
  20. GUCY2C as a biomarker to target precision therapies for patients with colorectal cancer.Expert review of precision medicine and drug development · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 4 countries.

Camille BalbinotUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, IRFAC UMR-S1113, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
Olivier ArmantKarlsruhe Institute of Technology, Institute of Toxicology and Genetics, Karlsruhe, Germany.ORCID 0000-0001-7101-9209
Nabila ElarouciCartes d'Identité des Tumeurs Program, Ligue Nationale Contre le Cancer, Paris, France.ORCID 0000-0002-7085-3274
Laetitia MarisaCartes d'Identité des Tumeurs Program, Ligue Nationale Contre le Cancer, Paris, France.ORCID 0000-0001-5529-7217
Elisabeth MartinUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, IRFAC UMR-S1113, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
Etienne De ClaraUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, IRFAC UMR-S1113, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
Alina OneaDépartement de Pathologie, Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France.
Jacqueline DeschampsDevelopmental Biology and Stem Cell Research, Hubrecht Institute, Utrecht, Netherlands.
Felix BeckBarts and The London School of Medicine and Dentistry, London, England, UK.ORCID 0000-0003-0420-7060
Jean-Noël FreundUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, IRFAC UMR-S1113, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France jean-noel.freund@inserm.fr.ORCID 0000-0002-0971-3774
Isabelle DulucUniversité de Strasbourg, Institut National de la Santé et de la Recherche Médicale, IRFAC UMR-S1113, Fédération de Médecine Translationnelle de Strasbourg, Strasbourg, France.
Inserm · FRLa Ligue Contre le Cancer · FRHôpitaux Universitaires de Strasbourg · FRHubrecht Institute for Developmental Biology and Stem Cell Research · NLKarlsruhe Institute of Technology · DEQueen Mary University of London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developmental genes contribute to cancer, as reported for the homeobox gene

Indexed as

AnimalsCarcinogenesisCDX2 Transcription FactorCecumColonic NeoplasmsGene Expression Regulation, NeoplasticHeterozygoteHumansIntestinal NeoplasmsIntestinesMetaplasiaMiceNeoplastic Stem CellsNF-kappa BNitric Oxide Synthase Type IIStromal CellsCDX2 Transcription FactorNF-kappa BNitric Oxide Synthase Type II

Identifiers

PMID29439001
PMCPMC5839756
OpenAlexW2793500447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.